Position in LGND
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$1,129,819
+$60,061 QoQ
Shares Held
5,659
+0.0% QoQ
Ownership
0.028%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in LGND Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026QUADRANT CAPITAL GROUP LLC holds $22,161,348 across 129 Biotechnology names. LGND ranks #8 (5.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
3,677 | $2,840,997 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
5,716 | $2,552,422 | |
| 3 | ARGX |
Argenx SE
|
2,778 | $2,028,634 | |
| 4 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
2,605 | $1,363,639 | |
| 5 | ROIV |
Roivant Sciences Ltd.
|
49,144 | $1,361,288 | |
| 6 | EXEL |
Exelixis, Inc.
|
28,474 | $1,221,249 | |
| 7 | BMRN |
Biomarin Pharmaceutical Inc
|
20,772 | $1,173,410 | |
| 8 | LGND |
Ligand Pharmaceuticals Inc
This page
|
5,659 | $1,129,819 |
All Filings in LGND
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,129,819 | 5,659 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $1,069,758 | 5,658 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $1,002,258 | 5,658 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $643,201 | 5,658 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $623,059 | 5,926 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $3,964 | 37 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $3,703 | 37 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $3,117 | 37 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $2,704 | 37 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $2,642 | 37 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $8,808 | 147 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $18,313 | 254 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $18,169 | 247 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $9,352 | 140 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $8,218 | 153 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $890 | 16 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $842 | 12 | Shares | Sole | 2022-05-06 | |
| 2021-12-31 | $1,156 | 12 | Shares | Sole | 2022-02-01 | |
| 2021-09-30 | $1,564 | 18 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $982 | 12 | Shares | Sole | 2021-08-09 | |
| 2021-03-31 | $1,141 | 12 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $744 | 12 | Shares | Sole | 2021-02-16 | |
| 2020-06-30 | $3,418 | 49 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $26,310 | 580 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||